Searchable abstracts of presentations at key conferences in endocrinology

ea0081p712 | Reproductive and Developmental Endocrinology | ECE2022

Phenotypic and genotypic heterogeneity of sexual development disorders 46, XY in the Tunisian population

Haj Kacem Akid Faten , Abdellahi Mohamed Ahmed Mohamed , Nessrine Dhieb , B Benrhouma , T Kammoun , M Hachicha , N Kallel , N Belguith , Mnif Mouna , Abid Mohamed

Introduction: Sexual disorders 46 XY DSD are responsible for a range of phenotypic disorders, ranging from an ambiguous phenotype to a complete female phenotype. In this context, we report a cohort of 22 46 XY patients with a female phenotype in order to establish a phenotype-genotype correlation.Results: The average age at diagnosis was 15.5 years (E: 7 days-33 years). The reason for consultation was primary amenorrhea in 16 cases (72.7%), sexual ambigu...

ea0029p1383 | Pituitary Clinical | ICEECE2012

No evidence for detrimental effect of cabergoline therapy on cardiac valves in patients with acromegaly

Maione L. , Garcia C. , Kallel N. , Bouchachi A. , Maison P. , Kamenicky P. , Salenave S. , Young J. , Assayag P. , Chanson P.

Context: The effects of cabergoline on cardiac valves have been extensively studied in Parkinson’s disease and hyperprolactinemia but not in acromegaly, a condition at risk of cardiac valve abnormalities.Objective: We examined the prevalence of heart valve disease and regurgitation in a series of patients with acromegaly treated with cabergoline, by comparison with matched patients who had never received this drug.Design and s...